Showing results (571-580 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|October 24, 2002
A phase II study of dose-dense docetaxel and mitoxantrone in the treatment of patients with high-risk metastatic breast cancerEllen König, Christian Kurbacher, Martin Schwonzen, et al.Anti-Cancer Drugs|October 24, 2002
Farnesyl transferase inhibitors: a major breakthrough in anticancer therapy? Naples, 12 April 2002Francesco CaponigroAnti-Cancer Drugs|November 20, 2002
Treatment of Kaposi's sarcoma--an updateElena Toschi, Cecilia Sgadari, Paolo Monini, et al.Anti-Cancer Drugs|November 20, 2002
Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancerMartina E Schiebe, Thomas Reese, Frederik Wenz, et al.Anti-Cancer Drugs|November 20, 2002
DNA damage and repair in BCR/ABL-expressing cells after combined action of idarubicin, STI571 and amifostineJanusz Blasiak, Ewa Gloc, Tomasz Pertyński, et al.Anti-Cancer Drugs|March 14, 2003
Magnolol induces apoptosis in human leukemia cells via cytochrome c release and caspase activationWen-Bin Zhong, Chih-Yuan Wang, Kuo-Jang Ho, et al.Anti-Cancer Drugs|March 14, 2003
Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystinSu Yeong Seo, Eun Joo Jun, Sung Moon Jung, et al.Anti-Cancer Drugs|March 14, 2003
Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancerChristine E Swenson, Lois E Bolcsak, Gerald Batist, et al.Anti-Cancer Drugs|March 14, 2003
Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemiaMaki Takabayashi, Rika Sakai, Hiroshi Sakamoto, et al.Anti-Cancer Drugs|April 8, 2003
Survival and prognostic factors of patients with unresectable glioblastoma multiformeBarbara Fazeny-Dörner, Catharina Wenzel, Mario Veitl, et al.Pageof 464